98 related articles for article (PubMed ID: 2676150)
1. Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia.
Cohen JD; Robins HI; Schmitt CL; Tanner MA
Cancer Res; 1989 Nov; 49(21):5805-9. PubMed ID: 2676150
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro.
Cohen JD; Robins HI
Cancer Res; 1987 Aug; 47(16):4335-7. PubMed ID: 3300964
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of human T-cell leukemia by thymidine and 41.8 degrees C hyperthermia in vitro.
Cohen JD; Schmitt CL; Robins HI
Radiat Res; 1991 Jun; 126(3):372-8. PubMed ID: 2034793
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
Anticancer Res; 1990; 10(3):805-11. PubMed ID: 2195988
[TBL] [Abstract][Full Text] [Related]
7. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Cohen JD; Robins HI; Schmitt CL
Cancer Lett; 1989 Mar; 44(3):205-10. PubMed ID: 2647285
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
Swinnen LJ; Ellis NK; Erickson LC
Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517
[TBL] [Abstract][Full Text] [Related]
9. Thymidine-cisplatin vs thymidine-carboplatin interactions in human T-cell acute leukemia.
Cohen JD; Robins HI
Leuk Res; 1991; 15(10):953-6. PubMed ID: 1921454
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.
Cohen JD; Robins HI; Javid MJ
J Neurooncol; 1990 Aug; 9(1):1-8. PubMed ID: 2213112
[TBL] [Abstract][Full Text] [Related]
11. Interactions between hyperthermia and irradiation in two human lymphoblastic leukemia cell lines in vitro.
Cohen JD; Robins HI; Mulcahy RT; Gipp JJ; Bouck N
Cancer Res; 1988 Jul; 48(13):3576-80. PubMed ID: 3259904
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line.
Murray TG; Cicciarelli N; McCabe CM; Ksander B; Feuer W; Schiffman J; Mieler WF; O'Brien JM
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2516-22. PubMed ID: 9375570
[TBL] [Abstract][Full Text] [Related]
13. Interaction of PtCl4(Fast Black)2 with hyperthermia.
Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS
Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969
[TBL] [Abstract][Full Text] [Related]
14. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
Herman TS; Teicher BA; Collins LS
Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
[TBL] [Abstract][Full Text] [Related]
17. Interaction of two second generation platinum antitumor drugs with mouse thymocytes.
Simpkins H; Pearlman LF
Cancer Res; 1986 Mar; 46(3):1433-9. PubMed ID: 3510724
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
19. Role of carbonate in the cytotoxicity of carboplatin.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
[TBL] [Abstract][Full Text] [Related]
20. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]